Overview

The DINE-GLP1 study aims to understand how people on GLP-1 therapy change their eating habits and what kind of dietary support they need. As more people use GLP-1 medications, there's not much guidance on what they should eat, mostly just focusing on managing symptoms and cutting calories. Since these medications reduce food intake, it's important to ensure the diet is nutritious even with fewer calories to help with long-term weight control and health. Most research has looked at how the body responds to the medication and whether patients take it as prescribed, but not much is known about what patients actually experience, what they think they need, or how they could use additional support. Understanding patients' views can help create better lasting solutions.

Eligibility

Inclusion Criteria:

• Adults aged 18 and older
• Recently has been prescribed GLP-1 therapy for the treatment of obesity or T2DM but have not yet initiated the medication
• Has regular access to a smartphone and internet to complete short surveys and food recalls online
• Willing to sign informed consent.

Exclusion Criteria:

• Already began the GLP-1 medication
• Have medical concerns making participation unsafe